Three-dimensional (3D) technique of restricting scrambling is changing the ways of drug design, labeling and production in the area of digital health. By combining digital and genetic techniques, Fused Deposition Modeling (FDM) can manufacture normalization systems. Consecutively, such a method can allow for speedy improvements in the healthcare systems, allowing the allocation of medicines based on patient’s needs and requirements. So far, several 3D based medicinal goods have been marketed. These include the production of implants and several useful related products for use in medical applications. Nevertheless, regulatory obstacles remain with developing medicines. This article reviews the latest FDM technology in medical and pharmaceutical research, including a discussion of the potential challenges in the field. Emphasis has been paid on future developments needed for facilitating the FDM integration into dispensaries and clinics.